Hence, it is advised to strictly follow clinical practice guidelines and conduct a risk assessment for PN before administering potentially neurotoxic medications to MM patients (Richardson et al., 2012)
All of this combines into a set of very good reasons why the FDA doesn't approve its use outside of specific conditions that are related to hGH deficiency in the first place
In addition, phenotyping using EHR diagnostic codes has known limitations 73 , but additional clinical data that may assist with more precise phenotyping, such as imaging, testing, and free-text notes, are currently not available in All of Us
Houghton, Christine A., Robert G
"Our Dip & Dap Duos are the matching colors to our Dip & Dap Powder line
Gut Health Support BPC-157 has shown promise in supporting gastrointestinal health